|
Volumn 14, Issue 6, 1997, Pages 372-388
|
Present and future of fluoroquinolones;PRESENTE Y FUTURO DE LAS FLUOROQUINOLONAS
a a a a a a |
Author keywords
Fluoroquinolones; In vitro activity; New perspectives; Pharmacology
|
Indexed keywords
8 CHLORO 1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4.3.0]NON 8 YL) 6 FLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID;
AMIFLOXACIN;
BAMIPINE;
BETA LACTAM ANTIBIOTIC;
CHLOROQUINE;
CINOXACIN;
CIPROFLOXACIN;
DROXACIN;
ENOXACIN;
FLEROXACIN;
FLUMEQUINE;
GREPAFLOXACIN;
IRLOXACIN;
LEVOFLOXACIN;
LOMEFLOXACIN;
MILOXACIN;
NADIFLOXACIN;
NALIDIXIC ACID;
NORFLOXACIN;
OFLOXACIN;
OXOLINIC ACID;
PEFLOXACIN;
PIPEMIDIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ROSOXACIN;
RUFLOXACIN;
SPARFLOXACIN;
TIOXACIN;
TOSUFLOXACIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANAEROBIC BACTERIUM;
ANTIBACTERIAL ACTIVITY;
CHLAMYDIACEAE;
DRUG BLOOD LEVEL;
DRUG RESISTANCE;
DRUG TISSUE LEVEL;
GASTROINTESTINAL DISEASE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
IN VITRO STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MUTATION;
MYCOBACTERIUM;
MYCOPLASMA;
NEUROTOXICITY;
NONHUMAN;
RESPIRATORY TRACT INFECTION;
REVIEW;
SKIN TOXICITY;
STRUCTURE ACTIVITY RELATION;
URINARY TRACT INFECTION;
|
EID: 0030847933
PISSN: 02126583
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (113)
|